GLASS LAB · Medical Aesthetics Evidence Index 303 cells · 19,226 papers · 5,969 top-tier evidence

Hair Restoration · Androgenetic alopecia - female

Stem cell SVF injection evidence for Androgenetic alopecia - female

B 53.5 / 100 Supported 7 RCT/meta · 4 clinical/observational · 2 case · 29 total
Good evidence · positive conclusion

There is a relatively good level of clinical evidence, and a majority of papers support its effectiveness.

Grade combines the quantity and quality of the research, while direction is a separate signal showing how the papers assess effectiveness.

Includes meta-analysis/SR Median year 2022 Last 5 years 59% Positive results 48% Negative results 2 Korea/Asia 1

Known in Korea as

줄기세포SVF 줄기세포

Procedure and brand names vary, but the evidence above applies to the same procedure mechanism.

Key papers

tier1 Evaluation of the effects of adding an adipose tissue-derived stromal vascular fraction to platelet-rich plasma injection in the treatment of androgenetic alopecia: A randomized clinical trial. Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) · 2024 · PMID 38634195

Abstract summary (English) BACKGROUND: Stromal vascular fraction (SVF) cells derived from adipose tissue and platelet-rich plasma (PRP) are among novel treatments for androgenetic alopecia (AGA). We aimed to investigate the effect of adding SVF to PRP and compare it to administering PRP injection alone. METHODS: Eighteen patients were randomly divided into two groups of nine.

Randomized Controlled Trial, Journal Article

View on PubMed
tier1 Adipose-derived stromal vascular fraction (SVF) for the treatment of androgenic alopecia (AGA): a systematic review. Acta bio-medica : Atenei Parmensis · 2023 · PMID 37850761

Abstract summary (English) BACKGROUND AND AIM: Androgenetic alopecia (AGA) is a common chronic, hereditary, cutaneous and androgen-dependent condition. Low self-esteem and negatively impact quality of life are often consequences of AGA. Clinical treatment of AGA using SVF (Stromal vascular fraction) has been effective.

Systematic Review, Journal Article

View on PubMed
tier1 Systematic review of exosome treatment in hair restoration: Preliminary evidence, safety, and future directions. Journal of cosmetic dermatology · 2023 · PMID 37381168

Abstract summary (English) BACKGROUND: Exosomes are small extracellular vesicles with potential roles in modulating the hair growth cycle and are an emerging therapy for patients with alopecia. In recent years, researchers have made significant progress in deciphering the network of cellular interactions and signaling pathways mediated by the transfer of exosomes. This has opened the door to a wide range of potential therapeutic applications...

Systematic Review, Journal Article

View on PubMed
tier1 Combination of adipose-derived stem cell conditioned media and minoxidil for hair regrowth in male androgenetic alopecia: a randomized, double-blind clinical trial. Stem cell research & therapy · 2023 · PMID 37605227

Abstract summary (English) INTRODUCTION: Treatments for AGA have yet to produce satisfactory outcomes and may cause intolerable side effects. Recent studies have reported that adipose tissue-derived stem cell conditioned media (ADSC-CM) could induce hair growth and regeneration. OBJECTIVE: To investigate the efficacy of ADSC-CM combined with minoxidil for hair regeneration therapy in male AGA.

Randomized Controlled Trial, Journal Article, Research Support, Non-U.S. Gov't

View on PubMed
tier1 The safety and efficacy of autologous adipose-derived stromal vascular fraction for nonscarring alopecia: A systematic review. Archives of dermatological research · 2021 · PMID 34014340

Abstract summary (English) IMPORTANCE: Nonscarring alopecia, including androgenetic alopecia and alopecia areata, are common and can negatively impact quality of life. Recent clinical studies have investigated autologous, adipose-derived stromal vascular fraction (SVF) as a potentially beneficial treatment option. OBJECTIVE: To assess the available evidence on the utility and safety of SVF for nonscarring alopecia.

Journal Article, Systematic Review

View on PubMed
tier1 The Effect of Conditioned Media From Human Adipocyte-Derived Mesenchymal Stem Cells on Androgenetic Alopecia After Nonablative Fractional Laser Treatment. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] · 2020 · PMID 32769526

Abstract summary (English) BACKGROUND: The conditioned media from adipocyte-derived mesenchymal stem cells-conditioned media (ADSC-CM) contains cytokines and growth factors that stimulate hair regeneration. OBJECTIVE: We evaluated the efficacy and safety of human ADSC-CM treatment on patients who underwent nonablative fractional laser for the treatment of androgenetic alopecia (AGA). MATERIALS AND METHODS: Thirty patients who underwent...

Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't

View on PubMed
tier1 A randomized, double-blind, vehicle-controlled clinical study of hair regeneration using adipose-derived stem cell constituent extract in androgenetic alopecia. Stem cells translational medicine · 2020 · PMID 32420695

Abstract summary (English) Accumulating evidence suggests that adipose-derived stem cell constituent extract (ADSC-CE) helps hair regrowth in patients with androgenetic alopecia (AGA). However, the effects of ADSC-CE have not been demonstrated in a randomized, double-blind, vehicle-controlled clinical trial. In this randomized, double-blind, vehicle-controlled clinical trial, 38 patients (29 men) with AGA were assigned to an intervention...

Journal Article, Randomized Controlled Trial

View on PubMed
tier2 Hair regeneration in androgenetic alopecia using secretome of adipose-derived stem cells (ADSC) and minoxidil: a comparative study of three groups. Archives of dermatological research · 2025 · PMID 40021536

Abstract summary (English) Androgenetic alopecia is one of the most common cause of hair loss disorder. This hereditary and androgen-dependent disorder tends to progress into partial or even complete baldness Several therapeutic options are now available for AGA, including conventional medications such as finasteride, dutasteride, and minoxidil. However, side effects of these medications are also commonly reported.

Clinical Trial, Comparative Study, Journal Article

View on PubMed
tier2 Sequential Scalp Assessment in Hair Regeneration Therapy Using an Adipose-Derived Stem Cell-Conditioned Medium. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] · 2020 · PMID 31490301

Abstract summary (English) BACKGROUND: An adipose-derived stem cell-conditioned medium (ADSC-CM) reportedly exerts skin-rejuvenating and hair growth-promoting effects. In the therapeutic application of ADSC-CM for alopecia, changes to the interfollicular scalp remain unclear although some evidence has indicated hair growth-promoting effects. OBJECTIVE: To evaluate the effects of ADSC-CM not only on hair follicles, but also on the...

Clinical Trial, Journal Article

View on PubMed
tier2 Stromal vascular fraction-enriched platelet-rich plasma therapy reverses the effects of androgenetic alopecia. Journal of cosmetic dermatology · 2019 · PMID 31541565

Abstract summary (English) BACKGROUND: Since antiquity, humans have been trying to devise remedies to cure androgenetic alopecia (AGA). These efforts include use of oral and topical concoctions and hair transplant strategies. As AGA affects people of all colors and creed, there has been a continuous effort to find a magic bullet against AGA.

Clinical Trial, Journal Article

View on PubMed

Suggested interpretation

Strong evidence base

Personalized evidence report

Tell us more about your concern
and the Glass Lab bot will build a personalized report for you.

Based on the Stem cell SVF injection · Androgenetic alopecia - female information on this page, we'll email you an evidence summary tailored to your skin condition and treatment stage.

Concerns of interest (select multiple)
Decision stage
← Other indications for the same procedure group  |  Other procedures for the same indication →